JPS58124786A - 新規な６−置換−ｓ−トリアゾロ〔３，４−ａ〕フタラジン誘導体 - Google Patents

新規な６−置換−ｓ−トリアゾロ〔３，４−ａ〕フタラジン誘導体

Info

Publication number
JPS58124786A
JPS58124786A JP58005413A JP541383A JPS58124786A JP S58124786 A JPS58124786 A JP S58124786A JP 58005413 A JP58005413 A JP 58005413A JP 541383 A JP541383 A JP 541383A JP S58124786 A JPS58124786 A JP S58124786A
Authority
JP
Japan
Prior art keywords
formula
phenyl
substituted
alkyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58005413A
Other languages
English (en)
Japanese (ja)
Other versions
JPH048428B2 (2
Inventor
エミリオ・オツチエルリ
ドメニコ・バロ−ネ
ジヨルジヨ・タルジア
アデレ・ジユンタ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of JPS58124786A publication Critical patent/JPS58124786A/ja
Publication of JPH048428B2 publication Critical patent/JPH048428B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP58005413A 1982-01-18 1983-01-18 新規な６−置換−ｓ−トリアゾロ〔３，４−ａ〕フタラジン誘導体 Granted JPS58124786A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8201273 1982-01-18
GB8201273 1982-01-18

Publications (2)

Publication Number Publication Date
JPS58124786A true JPS58124786A (ja) 1983-07-25
JPH048428B2 JPH048428B2 (2) 1992-02-17

Family

ID=10527683

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58005413A Granted JPS58124786A (ja) 1982-01-18 1983-01-18 新規な６−置換−ｓ−トリアゾロ〔３，４−ａ〕フタラジン誘導体

Country Status (20)

Country Link
US (1) US4788186A (2)
EP (1) EP0085840B1 (2)
JP (1) JPS58124786A (2)
KR (1) KR890000184B1 (2)
AT (1) ATE22562T1 (2)
AU (1) AU564026B2 (2)
CA (1) CA1214168A (2)
DE (1) DE3366494D1 (2)
DK (1) DK163145C (2)
ES (1) ES531458A0 (2)
FI (1) FI81350C (2)
GR (1) GR78442B (2)
HU (1) HU193033B (2)
IE (1) IE55032B1 (2)
IL (1) IL67697A (2)
NO (1) NO161674C (2)
NZ (1) NZ203021A (2)
PH (1) PH21834A (2)
PT (1) PT76107A (2)
ZA (1) ZA83224B (2)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001525802A (ja) * 1997-05-08 2001-12-11 メルク シヤープ エンド ドーム リミテツド ＧＡＢＡα５リガンドとしての置換１，２，４−トリアゾロ［３，４−ａ］フタラジン誘導体
JP2008526717A (ja) * 2005-01-05 2008-07-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング トリアゾロフタラジン
JP2008526716A (ja) * 2005-01-05 2008-07-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング トリアゾロフタラジン

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194310B (it) * 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
AU723098B2 (en) * 1996-07-25 2000-08-17 Merck Sharp & Dohme Limited Substituted triazolo-pyridazine derivatives as ligands for GABA receptors
JP2000515851A (ja) 1996-07-25 2000-11-28 メルク シヤープ エンド ドーム リミテツド ＧＡＢＡ▲下Ａα５▼レセプターサブタイプの逆アゴニストとしての置換のあるトリアゾロピリダジン誘導体
ES2137113B1 (es) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.
GB9715977D0 (en) * 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
AU1041599A (en) * 1997-11-13 1999-06-07 Jose Luis Castro Pineiro Therapeutic uses of triazolo-pyridazine derivatives
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
EP1047697A1 (en) * 1998-01-14 2000-11-02 MERCK SHARP & DOHME LTD. Triazolo-pyridazine derivatives as ligands for gaba receptors
AU748737B2 (en) * 1998-01-21 2002-06-13 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
GB9801234D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801210D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
SK12772000A3 (sk) * 1998-02-25 2001-03-12 Merck Sharp & Dohme Limited 3-(5-metylizoxazol-3-yl)-6-(1-metyl-1,2,3-triazol-4-yl)metyloxy- -1,2,4-triazolo[3,4-a]ftalazín, farmaceutický prostriedok s jeho obsahom a jeho požitie
KR20010041234A (ko) 1998-02-25 2001-05-15 더블유. 지. 콜 치환된 1,2,4-트리아졸로[3,4-ａ]피리다진
WO2000027849A2 (en) 1998-11-12 2000-05-18 Merck & Co., Inc. Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
GB9824897D0 (en) 1998-11-12 1999-01-06 Merck Sharp & Dohme Therapeutic compounds
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0028583D0 (en) 2000-11-23 2001-01-10 Merck Sharp & Dohme Therapeutic compounds
WO2002083064A2 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. A method of treating cancer
WO2002083140A1 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
US20060142178A1 (en) * 2002-04-08 2006-06-29 Barnett Stanley F Method of treating cancer
US20050054647A1 (en) * 2002-12-27 2005-03-10 Detlev Schuppan New pharmaceutical combination
BRPI0514586A (pt) * 2004-09-02 2008-06-17 Altana Pharma Ag triazolftalazinas
PH12012501361A1 (en) 2009-12-31 2012-10-22 Centro Nac De Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
CN103694244B (zh) * 2014-01-09 2016-03-30 郑州大学 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途
CN104016986B (zh) * 2014-03-13 2016-02-03 郑州大学 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途
EP4279074A1 (en) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Azolo compounds for treatment of fibrotic diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB629177A (en) * 1945-12-21 1949-09-14 Ciba Ltd Manufacture of new hydrazine compounds and derivatives thereof
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
JPS5132598A (en) * 1974-09-13 1976-03-19 Eisai Co Ltd Toriazoro * 3 44 ee * futarajinjudotai no goseiho
JPS603080B2 (ja) * 1976-08-10 1985-01-25 三菱化学株式会社 Ｓ―トリアゾロ〔３，４ ―α〕〔５，６，７，８〕テトラヒドロ フタラジン類
GR70309B (2) * 1979-10-29 1982-09-08 Dow Chemical Co

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001525802A (ja) * 1997-05-08 2001-12-11 メルク シヤープ エンド ドーム リミテツド ＧＡＢＡα５リガンドとしての置換１，２，４−トリアゾロ［３，４−ａ］フタラジン誘導体
JP2008526717A (ja) * 2005-01-05 2008-07-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング トリアゾロフタラジン
JP2008526716A (ja) * 2005-01-05 2008-07-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング トリアゾロフタラジン

Also Published As

Publication number Publication date
NZ203021A (en) 1986-05-09
ZA83224B (en) 1983-10-26
FI81350C (fi) 1990-10-10
CA1214168A (en) 1986-11-18
ES8601995A1 (es) 1985-11-01
US4788186A (en) 1988-11-29
JPH048428B2 (2) 1992-02-17
PH21834A (en) 1988-03-17
KR890000184B1 (ko) 1989-03-09
EP0085840B1 (en) 1986-10-01
AU564026B2 (en) 1987-07-30
KR840003254A (ko) 1984-08-20
PT76107A (en) 1983-02-01
FI830100A0 (fi) 1983-01-12
FI830100L (fi) 1983-07-19
NO161674C (no) 1989-09-13
NO161674B (no) 1989-06-05
ATE22562T1 (de) 1986-10-15
IE830082L (en) 1983-07-18
DE3366494D1 (de) 1986-11-06
DK163145C (da) 1992-06-22
DK17983A (da) 1983-07-19
ES531458A0 (es) 1985-11-01
HU193033B (en) 1987-08-28
GR78442B (2) 1984-09-27
EP0085840A1 (en) 1983-08-17
IE55032B1 (en) 1990-05-09
NO830110L (no) 1983-07-19
FI81350B (fi) 1990-06-29
IL67697A (en) 1990-02-09
IL67697A0 (en) 1983-05-15
DK163145B (da) 1992-01-27
DK17983D0 (da) 1983-01-18
AU1055083A (en) 1983-07-28

Similar Documents

Publication Publication Date Title
KR890000184B1 (ko) 신규 6-치환-s-트리아졸로[3,4-a]프탈라진 유도체의 제조방법
JP5649614B2 (ja) 有機化合物
JP5453086B2 (ja) 有機化合物
AU2004290643B2 (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines with PDE-5 inhibiting activity
EP4450504A1 (en) Heterocyclic compound having anti-tumor activity and use thereof
MX2014008201A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso.
JP2006508092A (ja) γ−セクレターゼの阻害のための環状スルファミド
JPH0256484A (ja) 縮合ピリミジン誘導体およびその製造方法
OA13170A (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors.
KR20020038942A (ko) 피라졸로[4,3-ｄ]피리미딘 유도체
HUE027771T2 (en) 1-Heterocyclyl-1,5-dihydro-pyrazolo [3,4-D] pyrimidin-4-one and their use as PDE9A modulators
JP4889480B2 (ja) ６−アリールメチル置換ピラゾロピリミジン類
JP2000128884A (ja) 性的機能障害の治療用のピラゾロピリミジノンｃＧＭＰＰＤＥ５阻害剤
AU2004235915B2 (en) 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
EP2864330A1 (en) Pyrrolopyrazone inhibitors of tankyrase
DK164704B (da) 3,6-disubstituerede triazolo-oe3,4-aaa-ftalazinderivater, fremgangsmaade til fremstilling deraf, udgangsforbindelse til anvendelse i fremgangsmaaden samt anvendelse af og farmaceutisk praeparat indeholdende forbindelserne
EP3307067A1 (en) Aminopyrazine compounds with a2a antagonist properties
JP2025508323A (ja) Ｃｄｋ４／６キナーゼの阻害薬
FI61899B (fi) Foerfarande foer framstaellning av antiflogistiska och antitrombotiska 6-substituerad-3-amino-4-fenyl-1h-pyrazolo/3,4-b/pyridiner
BR112019004982A2 (pt) 1-arilnaftiridina-3-carboxamidas 7-substituídas e seu uso.
WO1999065907A1 (en) Triazolo-pyrimidines as ligands for gaba receptors
JP5277303B2 (ja) ６−シクリルメチル−および６−アルキルメチル置換ピラゾロピリミジン類
CN114478537B (zh) 环酰胺并环化合物及其医药用途
NZ205387A (en) Substituted imidazo(1,2-a)pyrimidine derivatives,methods for their preparation and pharmaceutical compositions
CN113045569A (zh) 用作ret激酶抑制剂的化合物及其应用